" 启示生物科学 " 报告2025年第3季度财政情况,没有新的临床或监管里程碑。 Revelation Biosciences reported Q3 2025 financials with no new clinical or regulatory milestones.

启示生物科学公司报告了2025年第三季度和前九个月的财务结果,披露了收入和运营费用,没有提到新的临床试验更新或产品批准. Revelation Biosciences reported financial results for the third quarter and first nine months of 2025, disclosing revenue and operating expenses, with no new clinical trial updates or product approvals mentioned. 该公司指出,它正在努力推进编审中候选人的工作,但没有提供在此期间取得的具体里程碑。 The company noted its ongoing efforts to advance pipeline candidates, but provided no specific milestones achieved during the period. 财务细节已作为定期报告周期的一部分发布。 Financial details were released as part of its regular reporting cycle.